Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
13:00
WEPDB0101
Validation of Alere TM q HIV-1/2 detect for detection of acute HIV infection at Anonymous Clinic, The Thai Red Cross AIDS Research Centre
Irin Srila-Or, The Thai Red Cross AIDS Research Centre, Thailand
Abstract
Slides
13:05
WEPDB0102
Favorable clinical phenotype reached in less than half of people treated in acute HIV infection
Jintanat Ananworanich, US Military HIV Research Program, United States
Abstract
Slides
13:10
WEPDB0103
Increasing contribution of integrated forms to total HIV1-DNA in blood, in primary infection during natural history - ANRS PRIMO and SEROCO cohorts
Véronique Avettand-Fenoel, Université Paris Descartes, France
Abstract
13:15
WEPDB0104
Intermittent viremia after treatment interruption increased risk of ART resumption in post-treatment HIV-1 controllers. ANRS VISCONTI study
Laurent Hocqueloux, CHR d'Orléans - La Source, France
Abstract
13:20
WEPDB0105
Auranofin plus nicotinamide impact HIV reservoir among ART suppressed HIV individuals
Ricardo Sobhie Diaz, Federal University of Sao Paulo, Brazil
Abstract
Slides
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT